Insider · CIK 0001522780

Kaye Edward M. MD

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001522780

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-16	CYTKCYTOKINETICS INCA Award	Director	AAward	+195 sh	$63.92	+$12.5K	10,629
2026-08-18	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−11.9K sh	$32.01	−$382K	125,194
2026-08-18	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−637 sh	$32.47	−$20.7K	124,557
2026-08-14	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.3K sh	—	—	137,124
2026-08-14	STOKStoke Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.3K sh	—	—	0
2026-07-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+151 sh	$82.62	+$12.5K	10,434
2026-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,786
2026-06-01	CYTKCYTOKINETICS INCS Sale	Director	SSale	−2,933 sh	$76.09	−$223K	10,283
2026-05-27	CYTKCYTOKINETICS INCA Award	Director	AAward	+2,851 sh	—	—	13,216
2026-05-27	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+4,301 sh	—	—	4,301
2026-04-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+191 sh	$65.37	+$12.5K	10,365
2026-03-15	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.5K sh	—	—	84,624
2026-03-15	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.3K sh	—	—	110,874
2026-03-15	STOKStoke Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.5K sh	—	—	35,500
2026-03-15	STOKStoke Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.3K sh	—	—	52,500
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,534 sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,692 sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.3K sh	—	—	0
2026-01-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+197 sh	$63.44	+$12.5K	10,174
2025-12-08	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−3,825 sh	$31.44	−$120K	58,729
2025-12-08	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−8,274 sh	$32.52	−$269K	50,455
2025-12-08	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−1,331 sh	$33.10	−$44.1K	49,124
2025-12-05	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−6,367 sh	$31.33	−$199K	64,735
2025-12-05	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−1,681 sh	$31.15	−$52.4K	63,054
2025-12-05	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−500 sh	$31.85	−$15.9K	62,554
2025-12-04	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−5,222 sh	$30.76	−$161K	72,333
2025-12-04	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−1,231 sh	$31.32	−$38.6K	71,102
2025-12-03	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−419 sh	$30.34	−$12.7K	51,956
2025-12-03	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−651 sh	$30.85	−$20.1K	51,305
2025-12-03	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.3K sh	—	—	77,555
2025-12-03	STOKStoke Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.3K sh	—	—	0
2025-12-02	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−661 sh	$29.56	−$19.5K	52,780
2025-12-02	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−405 sh	$30.14	−$12.2K	52,375
2025-12-01	STOKStoke Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,317 sh	—	—	0
2025-12-01	CYTKCYTOKINETICS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,064 sh	$12.40	+$100K	18,041
2025-12-01	CYTKCYTOKINETICS INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$14.25	+$285K	38,041
2025-12-01	CYTKCYTOKINETICS INCS Sale	Director	SSale	−28.1K sh	$66.72	−$1.87M	9,977
2025-12-01	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,064 sh	—	—	0
2025-12-01	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2025-11-11	CYTKCYTOKINETICS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,175 sh	$9.66	+$50K	15,152
2025-11-11	CYTKCYTOKINETICS INCS Sale	Director	SSale	−5,175 sh	$65.08	−$337K	9,977
2025-11-11	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,175 sh	—	—	0
2025-10-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+199 sh	$62.80	+$12.5K	9,977
2025-10-08	STOKStoke Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$0.60	+$15K	74,124
2025-10-08	STOKStoke Therapeutics, Inc.S Sale	Director	SSale	−25K sh	$30.00	−$750K	49,124

Recent filings

Accepted (ET)
Oct 204
Kaye Edward M. MD0001061983-26-000105
SEC(opens sec.gov)
Aug 184
Kaye Edward M. MD0001522780-26-000007
SEC(opens sec.gov)
Jul 164
Kaye Edward M. MD0001061983-26-000081
SEC(opens sec.gov)
Jun 54
Kaye Edward M. MD0001522780-26-000004
SEC(opens sec.gov)
Jun 14
Kaye Edward M. MD0001061983-26-000066
SEC(opens sec.gov)
May 274
Kaye Edward M. MD0001061983-26-000058
SEC(opens sec.gov)
Apr 154
Kaye Edward M. MD0001061983-26-000040
SEC(opens sec.gov)
Mar 174
Kaye Edward M. MD0001522780-26-000002
SEC(opens sec.gov)
Feb 274
Kaye Edward M. MD0001193125-26-082136
SEC(opens sec.gov)

Companies

Address

350 OYSTER POINT BLVD

SOUTH SAN FRANCISCO, CA, 94080